Pharma Foods International Dirección

Dirección controles de criterios 2/4

El CEO de Pharma Foods International's es Yongsook Kim, nombrado en Nov 1999, tiene una permanencia de 24.42 años. posee directamente un 14.22% de las acciones de la empresa, con un valor de ¥3.31B. La antigüedad media del equipo directivo y de la junta directiva es de 4.1 años y 8.5 años, respectivamente.

Información clave

Yongsook Kim

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	24.6yrs
Participación del CEO	14.2%
Permanencia media de la dirección	4.3yrs
Promedio de permanencia en la Junta Directiva	8.7yrs

Actualizaciones recientes de la dirección

Recent updates

We Like Pharma Foods International's (TSE:2929) Earnings For More Than Just Statutory Profit

Mar 23

CEO

Yongsook Kim (77 yo)

24.6yrs

Permanencia

Mr. Mu Jo Kim, also known as Yongsook, is the Chief Executive Officer of Pharma Foods International Co., Ltd. He has been the President of Pharma Foods International Co., Ltd. since November 1999 and serve...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Mu Jo Kim	CEO, President & Director	24.6yrs	sin datos	14.22% ¥ 3.4b
Noriko Horie	Head Office Sales Person & Director	no data	sin datos	0.31% ¥ 74.7m
Kazuyuki Masuda	Senior MD	7.8yrs	sin datos	2.55% ¥ 617.1m
Yasunori Inoue	MD, Tokyo Sales Representative & Director	no data	sin datos	0.062% ¥ 15.0m
Yong-il Kim	GM of Development Department & Director	less than a year	sin datos	sin datos
Hirotaka Higashiyama	In Charge of Management Department & Director	less than a year	sin datos	0.0022% ¥ 537.2k

4.3yrs

Permanencia media

48.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 2929 se considera experimentado (4.1 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Mu Jo Kim	CEO, President & Director	no data	sin datos	14.22% ¥ 3.4b
Noriko Horie	Head Office Sales Person & Director	13yrs	sin datos	0.31% ¥ 74.7m
Kazuyuki Masuda	Senior MD	15.7yrs	sin datos	2.55% ¥ 617.1m
Yasunori Inoue	MD, Tokyo Sales Representative & Director	4.7yrs	sin datos	0.062% ¥ 15.0m
Yong-il Kim	GM of Development Department & Director	less than a year	sin datos	sin datos
Hirotaka Higashiyama	In Charge of Management Department & Director	less than a year	sin datos	0.0022% ¥ 537.2k
Nobuo Hatta	External Auditor	10.7yrs	sin datos	0.024% ¥ 5.9m
Shinya Samura	Outside Independent Director	8.7yrs	sin datos	0.068% ¥ 16.4m
Takashi Iino	Head of Audit & Supervisory Board	14.7yrs	sin datos	0.070% ¥ 17.0m
Shinya Tsujimoto	External Auditor	13.7yrs	sin datos	0.036% ¥ 8.6m
Tetsuro Yamane	Outside Independent Director	5.7yrs	sin datos	sin datos
Taro Ueda	Outside Independent Director	2.7yrs	sin datos	sin datos

8.7yrs

Permanencia media

66yo

Promedio de edad

Junta con experiencia: La junta directiva de 2929 se considera experimentada (8.5 años de antigüedad promedio).

Pharma Foods International Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Pharma Foods International Co., Ltd., Annual General Meeting, Oct 25, 2023

No independent directors

No independent directors

Recent updates

Pharma Foods International Co., Ltd. to Report Q3, 2024 Results on Jun 10, 2024

We Like Pharma Foods International's (TSE:2929) Earnings For More Than Just Statutory Profit

Pharma Foods International Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending July 31, 2024

Second quarter 2024 earnings released: EPS: JP¥16.76 (vs JP¥31.44 in 2Q 2023)

Pharma Foods International Co., Ltd. to Report Q2, 2024 Results on Mar 11, 2024

Upcoming dividend of JP¥10.00 per share at 1.9% yield

Investor sentiment improves as stock rises 15%

First quarter 2024 earnings released: EPS: JP¥9.92 (vs JP¥62.76 loss in 1Q 2023)

Pharma Foods International Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending July 31, 2024

New minor risk - Dividend sustainability

Pharma Foods International Co., Ltd. to Report Q1, 2024 Results on Dec 11, 2023

Pharma Foods International Co., Ltd. (TSE:2929) agreed to acquire Healthcare Mail Order Business Of Daicel from Daicel Corporation (TSE:4202).

Pharma Foods International Co., Ltd., Annual General Meeting, Oct 25, 2023

Full year 2023 earnings released: EPS: JP¥107 (vs JP¥12.89 loss in FY 2022)

Pharma Foods International Co., Ltd. to Report Fiscal Year 2023 Results on Sep 11, 2023

Upcoming dividend of JP¥12.00 per share at 1.2% yield

Third quarter 2023 earnings released: EPS: JP¥68.72 (vs JP¥63.54 loss in 3Q 2022)

Pharma Foods International Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending July 31, 2023

Second quarter 2023 earnings released: EPS: JP¥31.44 (vs JP¥11.38 in 2Q 2022)

Pharma Foods International Co., Ltd. to Report Q2, 2023 Results on Mar 07, 2023

Upcoming dividend of JP¥10.00 per share

First quarter 2023 earnings released: JP¥62.76 loss per share (vs JP¥42.44 profit in 1Q 2022)

Pharma Foods International Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending July 31, 2023

No independent directors

Pharma Foods International Co., Ltd. to Report Q1, 2023 Results on Dec 05, 2022

Pharma Foods International Co., Ltd. (TSE:2929) announces an Equity Buyback for 270,000 shares, representing 0.93% for ¥300 million.

Full year 2022 earnings released: JP¥12.89 loss per share (vs JP¥132 profit in FY 2021)

Pharma Foods International Co., Ltd. Declares Dividend for the Year Ended July 30, 2022, Payable on October 21, 2022

Pharma Foods International Co., Ltd. to Report Fiscal Year 2022 Results on Sep 06, 2022

Upcoming dividend of JP¥10.00 per share

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: JP¥63.59 loss per share (vs JP¥68.78 profit in 3Q 2021)

Pharma Foods International Co., Ltd. to Report Q3, 2022 Results on Jun 03, 2022

No independent directors

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of JP¥10.00 per share

First quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings released: EPS JP¥132 (vs JP¥23.76 in FY 2020)

Pharma Foods International Co., Ltd. (TSE:2929) announces an Equity Buyback for 120,000 shares, representing 0.41% for ¥300 million.

Pharma Foods International Co., Ltd. (TSE:2929) completed the acquisition of unknown majority stake in Meiji Yakuhin Co.Ltd. from Toshimitsu Ishizaka and others.

Investor sentiment improved over the past week

Pharma Foods International Co., Ltd. (TSE:2929) agreed to acquire unknown majority stake in Meiji Yakuhin Co.Ltd. from Toshimitsu Ishizaka and others.

Upcoming dividend of JP¥10.00 per share

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS JP¥68.78 (vs JP¥46.21 in 3Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS JP¥33.77 (vs JP¥25.97 loss in 2Q 2020)

New 90-day high: JP¥3,400

Pharma Foods International Co., Ltd. Enters into Exclusive Licensing Agreement with Mitsubishi Tanabe Pharma Corporation for A New Therapeutic Antibody to Treat Autoimmune Diseases

Upcoming Dividend of JP¥5.00 Per Share

Pharma Foods International Co., Ltd. to Report Q2, 2021 Results on Mar 05, 2021

First quarter 2021 earnings released: JP¥49.14 loss per share

First quarter 2021 earnings released: JP¥49.14 loss per share

Pharma Foods International Co., Ltd. to Report Fiscal Year 2020 Results on Sep 07, 2020

CEO

Permanencia

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad